Page last updated: 2024-10-17

2-aminoadipic acid and Autosomal Dominant Juvenile Parkinson Disease

2-aminoadipic acid has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies

2-Aminoadipic Acid: A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; (NMDA).
2-aminoadipic acid : An alpha-amino acid that is adipic acid bearing a single amino substituent at position 2. An intermediate in the formation of lysine.

Research Excerpts

ExcerptRelevanceReference
"Neuroinflammation is a contributory factor underlying the progressive nature of dopaminergic neuronal loss within the substantia nigra (SN) of Parkinson's disease (PD) patients, albeit the role of astrocytes in this process has been relatively unexplored to date."1.51L-alpha-aminoadipic acid restricts dopaminergic neurodegeneration and motor deficits in an inflammatory model of Parkinson's disease in male rats. ( Chiara Goisis, R; Harkin, A; Haverty, R; O'Neill, E, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Neill, E1
Chiara Goisis, R1
Haverty, R1
Harkin, A1

Other Studies

1 other study available for 2-aminoadipic acid and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
L-alpha-aminoadipic acid restricts dopaminergic neurodegeneration and motor deficits in an inflammatory model of Parkinson's disease in male rats.
    Journal of neuroscience research, 2019, Volume: 97, Issue:7

    Topics: 2-Aminoadipic Acid; Animals; Astrocytes; Corpus Striatum; Dopaminergic Neurons; Glial Fibrillary Aci

2019